메뉴 건너뛰기




Volumn 30, Issue 7, 2007, Pages 607-609

Signal detection: Historical background

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE DRUG REACTION; ADVERSE OUTCOME; CONFERENCE PAPER; DATA ANALYSIS; DATA BASE; DRUG MONITORING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HUMAN; METHODOLOGY; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SIGNAL DETECTION;

EID: 34447118881     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200730070-00006     Document Type: Conference Paper
Times cited : (15)

References (14)
  • 1
    • 0025330184 scopus 로고
    • Quality criteria for early signals of possible adverse drug reactions
    • Edwards IR, Lindquist M, Wiholm B-E, et al. Quality criteria for early signals of possible adverse drug reactions. Lancet 1990; 336 (8708): 156-8
    • (1990) Lancet , vol.336 , Issue.8708 , pp. 156-158
    • Edwards, I.R.1    Lindquist, M.2    Wiholm, B.-E.3
  • 2
    • 0020701395 scopus 로고
    • Identification of adverse reactions to new drugs. I: What have been the important adverse reactions since thalidomide?
    • Venning GR. Identification of adverse reactions to new drugs. I: what have been the important adverse reactions since thalidomide? Br Med J (Clin Res Ed) 1983; 286 (6360): 199-202
    • (1983) Br Med J (Clin Res Ed) , vol.286 , Issue.6360 , pp. 199-202
    • Venning, G.R.1
  • 3
    • 0020673316 scopus 로고
    • Identification of adverse reactions to new drugs. II: How were 18 important adverse reactions discovered and with what delays?
    • Venning GR. Identification of adverse reactions to new drugs. II: how were 18 important adverse reactions discovered and with what delays? Br Med J (Clin Res Ed) 1983; 286 (6361): 289-92
    • (1983) Br Med J (Clin Res Ed) , vol.286 , Issue.6361 , pp. 289-292
    • Venning, G.R.1
  • 4
    • 0020660173 scopus 로고
    • Identification of adverse reactions to new drugs. II (continued): How were 18 important adverse reactions discovered and with what delays?
    • Venning GR. Identification of adverse reactions to new drugs. II (continued): how were 18 important adverse reactions discovered and with what delays? Br Med J (Clin Res Ed) 1983; 286 (6362): 365-8
    • (1983) Br Med J (Clin Res Ed) , vol.286 , Issue.6362 , pp. 365-368
    • Venning, G.R.1
  • 5
    • 0020661623 scopus 로고
    • Identification of adverse reactions to new drugs. III: Alerting processes and early warning systems
    • Venning GR. Identification of adverse reactions to new drugs. III: alerting processes and early warning systems. Br Med J (Clin Res Ed) 1983; 286 (6363): 458-60
    • (1983) Br Med J (Clin Res Ed) , vol.286 , Issue.6363 , pp. 458-460
    • Venning, G.R.1
  • 6
    • 0020077383 scopus 로고
    • Validity of anecdotal reports of suspected adverse drug reactions: The problem of false alarms
    • Venning GR. Validity of anecdotal reports of suspected adverse drug reactions: the problem of false alarms. Br Med J (Clin Res Ed) 1982; 284 (6311): 249-52
    • (1982) Br Med J (Clin Res Ed) , vol.284 , Issue.6311 , pp. 249-252
    • Venning, G.R.1
  • 7
    • 0020675778 scopus 로고
    • Identification of adverse reactions to new drugs. IV: Verification of suspected adverse reactions
    • Venning GR. Identification of adverse reactions to new drugs. IV: verification of suspected adverse reactions. Br Med J (Clin Res Ed) 1983; 286 (6364): 544-7
    • (1983) Br Med J (Clin Res Ed) , vol.286 , Issue.6364 , pp. 544-547
    • Venning, G.R.1
  • 8
    • 0002327178 scopus 로고
    • The design and logic of a monitor of drug use
    • Finney DJ. The design and logic of a monitor of drug use. J Chronic Dis 1965; 18: 77-98
    • (1965) J Chronic Dis , vol.18 , pp. 77-98
    • Finney, D.J.1
  • 9
    • 47349113508 scopus 로고
    • Thalidomide and congenital abnormalities
    • Mcbride WG. Thalidomide and congenital abnormalities. Lancet 1961; 278 (7216): 1358
    • (1961) Lancet , vol.278 , Issue.7216 , pp. 1358
    • Mcbride, W.G.1
  • 10
    • 34447135716 scopus 로고
    • Canada
    • Inman WHW, editor, Lancaster: MTP Press
    • Napke E. Canada. In: Inman WHW, editor. Monitoring for drug safety. Lancaster: MTP Press, 1986: 65-6
    • (1986) Monitoring for drug safety , pp. 65-66
    • Napke, E.1
  • 11
    • 0036210975 scopus 로고    scopus 로고
    • A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions
    • van Puijenbroek EP, Bate A, Leufkens HG, et al. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf 2002; 11 (1): 3-10
    • (2002) Pharmacoepidemiol Drug Saf , vol.11 , Issue.1 , pp. 3-10
    • van Puijenbroek, E.P.1    Bate, A.2    Leufkens, H.G.3
  • 12
    • 16244414305 scopus 로고    scopus 로고
    • Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death
    • De Bruin ML, Pettersson M, Meyboom RHB, et al. Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death. Eur Heart J 2005; 26 (6): 590-7
    • (2005) Eur Heart J , vol.26 , Issue.6 , pp. 590-597
    • De Bruin, M.L.1    Pettersson, M.2    Meyboom, R.H.B.3
  • 13
    • 0029838837 scopus 로고    scopus 로고
    • Can adverse drug reactions be detected earlier? A comparison of reports by patients and professionals
    • Egberts TCG, Smulders M, De Koning FHP, et al. Can adverse drug reactions be detected earlier? A comparison of reports by patients and professionals. Br Med J 1996; 313 (7056): 530-1
    • (1996) Br Med J , vol.313 , Issue.7056 , pp. 530-531
    • Egberts, T.C.G.1    Smulders, M.2    De Koning, F.H.P.3
  • 14
    • 21744447422 scopus 로고    scopus 로고
    • Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK: Cohort study using data from the UK General Practice Research Database
    • Russmann S, Kaye J, Jick S, et al. Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK: Cohort study using data from the UK General Practice Research Database. Br J Clin Pharmacol 2005; 60 (1): 76-82
    • (2005) Br J Clin Pharmacol , vol.60 , Issue.1 , pp. 76-82
    • Russmann, S.1    Kaye, J.2    Jick, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.